The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open fo...
Australia-based Telix Pharmaceuticals has announced that the Brazilian Health Regulatory Agency (Agencia Nacional d...
British pharmaceutical firm AstraZeneca has entered into a definitive agreement to acquire Belgium-based biotech startup...
Elsevier, a global leader in advanced information and decision support, launches ScienceDirect AI, a cutting-edge g...
The year 2025 is set to be a pivotal year for the health, bioscience, and biopharma sectors, as emerging trends shape he...
Taiwan's Mycenax and Sartorius have entered into a strategic partnership to create comprehensive biopharmaceutical manuf...
Amid intensifying U.S.-China trade tensions, Beijing has escalated its retaliatory measures by banning U.S. biot...
To continue to help customers address the rapidly evolving cyber threat landscape, A10 Networks (NYSE: ATEN) has acquire...
Over the past decade, interest in Antibody-Drug Conjugates (ADCs) has surged, driven by their promise for patients, adva...
The first Antibody-Drug Conjugate (ADC) prototypes were developed more than 55 years ago by researchers of the Institut ...
Soon after being sworn in as the 47th President of the United States, Donald Trump signed an Executive Order to withdraw...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
This formal agreement establishes a collaborative framework between two like-minded, full-service Contract Res...
Novo Nordisk, a global leader in diabetes and obesity care, reported a stellar performance for the fourth quarter (Q4) a...
“We made good progress in 2024, which was capped by a fourth quarter of strong topline growth driven by key produc...
"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...
World Health Organization (WHO) and Encephalitis International have launched a critical Technical Brief on Encephalitis ...
"This transition is a testament to our commitment to both continuity and innovation," announced Merck KGaA, Darmstadt, G...
